Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment.
about
Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple SclerosisThe retrovirus/superantigen hypothesis of multiple sclerosis.Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.Geographic variations of multiple sclerosis prevalence in France: The latitude gradient is not uniform depending on the socioeconomic status of the studied population.Temporal relationship between environmental influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.Defining a role for laquinimod in multiple sclerosis.Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis.Cannabinoid control of neuroinflammation related to multiple sclerosis.A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?Biologically inspired approaches to drug delivery for nerve regeneration.Myelin repair: the role of stem and precursor cells in multiple sclerosisMature dendritic cells cause Th17/Treg imbalance by secreting TGF-β1 and IL-6 in the pathogenesis of experimental autoimmune encephalomyelitis.The benefits of exercise training in multiple sclerosis.Novel therapeutic options for multiple sclerosis.Is physical exercise a multiple sclerosis disease modifying treatment?Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple SclerosisThe Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.Use of natalizumab in patients with active relapsing-remitting multiple sclerosis in Kuwait.Multiple sclerosis: preventing progression and disability in MS-when to treat?Quality of life among multiple sclerosis patients in Saudi Arabia.Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords.Lesion enhancement diminishes with time in primary progressive multiple sclerosis.Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.MRI and multiple sclerosis-the evolving role of MRI in the diagnosis and management of MS: a clinician's perspective.
P2860
Q28267527-2AAE3257-AE64-4FFC-B67D-1B12E60E500FQ30317136-042C0DE0-4F5E-46E8-9FC6-F3E46B07A937Q33643239-2C2F03E2-3386-42AE-B236-37E4CFA4C7F0Q33692773-4CA1238C-3F9F-4E1E-ABCD-E94005EFD8FAQ33787783-D79AC0F0-5545-44A2-8F0B-8D70EFD690B9Q33810559-4659EBF8-36F7-4534-8431-4AFB414553EFQ33847350-CBDBE5D8-8523-423D-AEFE-9F67A1EB2405Q34035137-25C8284D-EB12-4FFD-A0C8-97A25A6CED8DQ34583231-B6232ECE-FEFB-45F7-B980-325953F46EF5Q35154139-5388CFC3-7840-4FA0-85FC-730A26E69CA9Q36359388-B551481E-9743-457B-BABA-3F9C08C08415Q36627231-6CE60C9E-FE1D-4097-8C18-87EA01B75004Q36729316-CBBEA6B0-A6AC-4281-B5B7-9C2A98121425Q37140600-EAD54BD5-8D6A-4082-9D54-0D909CC76BA6Q38028858-9C762D5E-55FA-40C6-9F78-E96990E010DFQ38170129-EA8DD715-70BD-4B6F-AED8-3F4184D077C6Q38843064-A42DBBF1-7BBC-4AA1-969E-54D5910FDBF2Q41173431-E7C215BC-6D65-4E8F-A005-852AB30E3B8BQ41475478-159CAD0C-130F-4E4F-872E-7CEEA672B6AEQ42288520-3F54537B-2D8F-4457-9F9D-13DC1B055557Q44793584-CC7F0FE5-03F8-4915-B269-F8A712C8973CQ47745308-C3B40ED5-BE0C-4198-B14B-97B62993E59CQ48099284-DA2EEBAD-6147-48BE-B464-4AC501EABBE6Q48283891-8A880501-C502-4189-BAFE-19D645EB390FQ48695171-5A323089-46A4-4F98-8E0E-0BB668FD063DQ50092008-DAB16E68-0519-4030-A07D-6E487A67839D
P2860
Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Accumulation of irreversible d ...... rom epidemiology to treatment.
@ast
Accumulation of irreversible d ...... rom epidemiology to treatment.
@en
type
label
Accumulation of irreversible d ...... rom epidemiology to treatment.
@ast
Accumulation of irreversible d ...... rom epidemiology to treatment.
@en
prefLabel
Accumulation of irreversible d ...... rom epidemiology to treatment.
@ast
Accumulation of irreversible d ...... rom epidemiology to treatment.
@en
P921
P1476
Accumulation of irreversible d ...... rom epidemiology to treatment.
@en
P2093
Christian Confavreux
Sandra Vukusic
P304
P356
10.1016/J.CLINEURO.2005.11.018
P577
2006-01-18T00:00:00Z